Regeneron’s antibody cocktail seems to reduce levels of coronavirus ... also had greater benefits in terms of symptom alleviation. Infusion reactions were seen in 4 patients (2 on placebo ...

Regeneron’s COVID-19 antibody cocktail has been added to the UK’s RECOVERY trial, one of the largest of its kind in the world that is testing several potential coronavirus therapies at the ...

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies ...

Donanemab is a monoclonal antibody given as an infusion. The medication binds to proteins that build up as amyloid plaques in the brain. By binding to the plaque proteins, the drug's antibodies ...

Emrelis is part of a class of medicines called antibody-drug conjugates (ADCs ... The medicine will be given as IV infusion every two weeks, for as long as the treatment works and the side ...

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

The use of polyclonal antibody preparations for immunosuppressive therapy in transplantation has been widely accepted for more than 2 decades. The earliest antibodies used in transplantation were ...

Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent ® (alirocumab) from competing in the market Jury awarded ...

The business reported a Net Interest Income (NII) registered a growth of 1.5% to ₹42,774 Crore versus ₹41,655 Crore in Q4FY24.